Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 1/2015

01-01-2015 | Opinion

Observation for newly diagnosed micro-papillary thyroid cancer: is now the time?

Author: F. Pacini

Published in: Journal of Endocrinological Investigation | Issue 1/2015

Login to get access

Excerpt

Following thyroid surgery for micro-papillary thyroid cancer (mPTC), the rate of disease-specific mortality is <1 %, of loco-regional recurrence is <5 %, and of distant recurrence is 1–2 % [1, 2], whatever the initial treatment. These excellent outcomes are likely related to the indolent nature of the disease rather than the effectiveness of treatment. …
Literature
1.
Hay ID (2007) Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13:521–533PubMedCrossRef
2.
Mazzaferri EL (2007) Management of low-risk differentiated thyroid cancer. Endocr Pract 13:498–512PubMedCrossRef
3.
Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381–387PubMedCrossRef
4.
Ito Y, Miyauchi A, Inoue H et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35PubMedCrossRef
5.
Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34:1222–1231PubMedCrossRef
6.
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167PubMedCrossRef
7.
Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, Angelos P, Grogan RH (2013) Cancer Epidemiol Biomark Prev. 22:1252–1259CrossRef
8.
Yu XM, Wan Y, Sippel RS, Chen H (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254:653–660PubMedCrossRef
9.
Momesso DP, Vaisman F, Caminha LS, Pessoa CH, Corbo R, Vaisman M (2014) Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer. J Endocrinol Invest 37:57–64PubMedCrossRef
10.
Ciampolillo A, Bellacicco M, Natalicchio A, Pezzolla A, Trerotoli P, Grammatica L, Achille G, Giorgino F (2011) Clinical aggressiveness of incidental and non-incidental thyroid cancer. J Endocrinol Invest 34:599–603PubMed
11.
Ahn D, Sohn JH, Jeon JH, Jeong JY (2014) Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid \carcinoma treated with hemithyroidectomy. J Endocrinol Invest 37:167–173PubMedCrossRef
Metadata
Title
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time?
Author
F. Pacini
Publication date
01-01-2015
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 1/2015
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0200-8

Other articles of this Issue 1/2015

Journal of Endocrinological Investigation 1/2015 Go to the issue

Erratum

Erratum to: GLP-1: benefits beyond pancreas

Short Review

Impact of maternal under nutrition on obstetric outcomes

Consensus Statement

Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology

Opinion

Effects of vitamin D supplements on bone density

Short Review

Spying on organelle Ca2+ in living cells: the mitochondrial point of view

Review

Treatment of post-menopausal osteoporosis: beyond bisphosphonates
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits